HYPR
Hyperfine Inc
NASDAQ: HYPR · HEALTHCARE · MEDICAL DEVICES
$1.87
+12.65% today
Updated 2026-05-01
Market cap
$163.54M
P/E ratio
—
P/S ratio
12.06x
EPS (TTM)
$-0.43
Dividend yield
—
52W range
$1 – $2
Volume
0.6M
Hyperfine Inc (HYPR) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $294000.00 | $1.50M | $6.81M | $11.03M | $12.89M | $13.56M |
| Revenue growth (YoY) | — | — | +408.8% | +355.5% | +61.9% | +16.8% | +5.2% |
| Cost of revenue | $0.00 | $771000.00 | $2.66M | $5.91M | $6.28M | $7.00M | $6.81M |
| Gross profit | $0.00 | $-477000.00 | $-1.17M | $907000.00 | $4.76M | $5.89M | $6.75M |
| Gross margin | — | -162.2% | -78.0% | 13.3% | 43.1% | 45.7% | 49.8% |
| R&D | $13.39M | $14.59M | $25.84M | $28.16M | $22.49M | $22.50M | $17.45M |
| SG&A | $5.81M | $5.92M | $27.50M | $32.41M | $20.28M | $17.49M | $16.25M |
| Operating income | $-19.97M | $-23.49M | $-64.87M | $-73.87M | $-48.12M | $-43.22M | $-37.09M |
| Operating margin | — | -7990.1% | -4336.1% | -1084.2% | -436.1% | -335.3% | -273.4% |
| EBITDA | $-19.83M | $-23.20M | $-64.14M | $-72.86M | $-47.06M | $-42.22M | $-34.88M |
| EBITDA margin | — | -7891.8% | -4287.6% | -1069.3% | -426.6% | -327.5% | -257.2% |
| EBIT | $-19.97M | $-23.49M | $-64.87M | $-73.87M | $-48.12M | $-43.22M | $-37.09M |
| Interest expense | $630000.00 | $70000.00 | $18000.00 | $710000.00 | — | — | — |
| Income tax | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-18.79M | $-23.36M | $-64.83M | $-73.16M | $-44.24M | $-40.72M | $-35.57M |
| Net income growth (YoY) | — | -24.3% | -177.6% | -12.8% | +39.5% | +8.0% | +12.6% |
| Profit margin | — | -7944.6% | -4333.8% | -1073.7% | -401.0% | -315.9% | -262.3% |